Skip to main content
Top
Published in: CEN Case Reports 2/2017

Open Access 01-11-2017 | Case report

Inherited, not acquired, Gitelman syndrome in a patient with Sjögren’s syndrome: importance of genetic testing to distinguish the two forms

Authors: Eikan Mishima, Takayasu Mori, Eisei Sohara, Shinichi Uchida, Takaaki Abe, Sadayoshi Ito

Published in: CEN Case Reports | Issue 2/2017

Login to get access

Abstract

Gitelman syndrome (GS) is an autosomal recessive, salt-losing renal tubulopathy caused by mutations in the SLC12A3 gene; however, it can also be acquired in patients with autoimmune disease, especially in those with Sjögren’s syndrome. Differentiating between the inherited and acquired forms of GS is clinically difficult. We report a case of inherited, not acquired, GS in a patient with Sjögren’s syndrome. A 41-year-old woman, who had been diagnosed with Sjögren’s syndrome at 27-years-old, had shown chronic hypokalemia (2.5–3.5 mmol/L). Laboratory tests showed hypokalemic alkalosis, hypomagnesemia, and hypocalciuria, corresponding to GS. Although acquired GS associated with Sjögren’s syndrome was initially suspected, a genetic test identified a novel homozygous mutation of c.1336-2A > T in the SLC12A3 gene, which resulted in aberrant splicing in the SLC12A3 transcript with the exclusion of exons 11 and 12. Thus, the GS was diagnosed as not the acquired but the inherited form. In the diagnosis of GS in patients with autoimmune disease, genetic testing of SLC12A3 is essential for differentiating the two forms.
Appendix
Available only for authorised users
Literature
1.
go back to reference Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, et al. Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet. 1996;12(1):24–30.CrossRef Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, et al. Gitelman’s variant of Bartter’s syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet. 1996;12(1):24–30.CrossRef
2.
go back to reference Casatta L, Ferraccioli GF, Bartoli E. Hypokalaemic alkalosis, acquired Gitelman’s and Bartter’s syndrome in chronic sialoadenitis. Br J Rheumatol. 1997;36(10):1125–8.CrossRef Casatta L, Ferraccioli GF, Bartoli E. Hypokalaemic alkalosis, acquired Gitelman’s and Bartter’s syndrome in chronic sialoadenitis. Br J Rheumatol. 1997;36(10):1125–8.CrossRef
3.
go back to reference Francois H, Mariette X. Renal involvement in primary Sjogren syndrome. Nat Rev Nephrol. 2016;12(2):82–93.CrossRef Francois H, Mariette X. Renal involvement in primary Sjogren syndrome. Nat Rev Nephrol. 2016;12(2):82–93.CrossRef
4.
go back to reference Chen YC, Yang WC, Yang AH, Lin SH, Li HY, Lin CC. Primary Sjogren’s syndrome associated with Gitelman’s syndrome presenting with muscular paralysis. Am J Kidney Dis. 2003;42(3):586–90.CrossRef Chen YC, Yang WC, Yang AH, Lin SH, Li HY, Lin CC. Primary Sjogren’s syndrome associated with Gitelman’s syndrome presenting with muscular paralysis. Am J Kidney Dis. 2003;42(3):586–90.CrossRef
5.
go back to reference Kim YK, Song HC, Kim WY, Yoon HE, Choi YJ, Ki CS, et al. Acquired Gitelman syndrome in a patient with primary Sjogren syndrome. Am J Kidney Dis. 2008;52(6):1163–7.CrossRef Kim YK, Song HC, Kim WY, Yoon HE, Choi YJ, Ki CS, et al. Acquired Gitelman syndrome in a patient with primary Sjogren syndrome. Am J Kidney Dis. 2008;52(6):1163–7.CrossRef
6.
go back to reference Schwarz C, Barisani T, Bauer E, Druml W. A woman with red eyes and hypokalemia: a case of acquired Gitelman syndrome. Wien Klin Wochenschr. 2006;118(7–8):239–42.CrossRef Schwarz C, Barisani T, Bauer E, Druml W. A woman with red eyes and hypokalemia: a case of acquired Gitelman syndrome. Wien Klin Wochenschr. 2006;118(7–8):239–42.CrossRef
7.
go back to reference Hinschberger O, Martzolff L, Ioannou G, Baumann D, Jaeger F, Kieffer P. Acquired Gitelman syndrome associated with Sjogren’s syndrome and scleroderma. Rev Med Interne. 2011;32(8):e96–8.CrossRef Hinschberger O, Martzolff L, Ioannou G, Baumann D, Jaeger F, Kieffer P. Acquired Gitelman syndrome associated with Sjogren’s syndrome and scleroderma. Rev Med Interne. 2011;32(8):e96–8.CrossRef
8.
go back to reference Kulkarni M, Kadri P, Pinto R. A case of acquired Gitelman syndrome presenting as hypokalemic paralysis. Indian J Nephrol. 2015;25(4):246–7.CrossRef Kulkarni M, Kadri P, Pinto R. A case of acquired Gitelman syndrome presenting as hypokalemic paralysis. Indian J Nephrol. 2015;25(4):246–7.CrossRef
9.
go back to reference Kusuda T, Hosoya T, Mori T, Ihara K, Nishida H, Chiga M, et al. Acquired Gitelman syndrome in an anti-SSA antibody-positive patient with a SLC12A3 heterozygous mutation. Intern Med. 2016;55(21):3201–4.CrossRef Kusuda T, Hosoya T, Mori T, Ihara K, Nishida H, Chiga M, et al. Acquired Gitelman syndrome in an anti-SSA antibody-positive patient with a SLC12A3 heterozygous mutation. Intern Med. 2016;55(21):3201–4.CrossRef
10.
go back to reference Kim YK, Song HC, Kim YS, Choi EJ. Acquired gitelman syndrome. Electrolyte Blood Press. 2009;7(1):5–8.CrossRef Kim YK, Song HC, Kim YS, Choi EJ. Acquired gitelman syndrome. Electrolyte Blood Press. 2009;7(1):5–8.CrossRef
11.
go back to reference Mori T, Hosomichi K, Chiga M, Mandai S, Nakaoka H, Sohara E, et al. Comprehensive genetic testing approach for major inherited kidney diseases, using next-generation sequencing with a custom panel. Clin Exp Nephrol. 2017;21(1):63–75.CrossRef Mori T, Hosomichi K, Chiga M, Mandai S, Nakaoka H, Sohara E, et al. Comprehensive genetic testing approach for major inherited kidney diseases, using next-generation sequencing with a custom panel. Clin Exp Nephrol. 2017;21(1):63–75.CrossRef
12.
go back to reference Li J, Lupat R, Amarasinghe KC, Thompson ER, Doyle MA, Ryland GL, et al. CONTRA: copy number analysis for targeted resequencing. Bioinformatics. 2012;28(10):1307–13.CrossRef Li J, Lupat R, Amarasinghe KC, Thompson ER, Doyle MA, Ryland GL, et al. CONTRA: copy number analysis for targeted resequencing. Bioinformatics. 2012;28(10):1307–13.CrossRef
13.
go back to reference Knoers NV, Levtchenko EN. Gitelman syndrome. Orphanet J Rare Dis. 2008;3:22.CrossRef Knoers NV, Levtchenko EN. Gitelman syndrome. Orphanet J Rare Dis. 2008;3:22.CrossRef
14.
go back to reference Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. The human gene mutation database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet. 2014;133(1):1–9.CrossRef Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. The human gene mutation database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet. 2014;133(1):1–9.CrossRef
15.
go back to reference Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S, et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 2016;44(D1):D862–8.CrossRef Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S, et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 2016;44(D1):D862–8.CrossRef
17.
go back to reference Genomes Project C, Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, et al. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061–73.CrossRef Genomes Project C, Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, et al. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061–73.CrossRef
18.
go back to reference Yamaguchi-Kabata Y, Nariai N, Kawai Y, Sato Y, Kojima K, Tateno M, et al. iJGVD: an integrative Japanese genome variation database based on whole-genome sequencing. Hum Genome Var. 2015;2:15050.CrossRef Yamaguchi-Kabata Y, Nariai N, Kawai Y, Sato Y, Kojima K, Tateno M, et al. iJGVD: an integrative Japanese genome variation database based on whole-genome sequencing. Hum Genome Var. 2015;2:15050.CrossRef
19.
go back to reference Vargas-Poussou R, Dahan K, Kahila D, Venisse A, Riveira-Munoz E, Debaix H, et al. Spectrum of mutations in Gitelman syndrome. J Am Soc Nephrol. 2011;22(4):693–703.CrossRef Vargas-Poussou R, Dahan K, Kahila D, Venisse A, Riveira-Munoz E, Debaix H, et al. Spectrum of mutations in Gitelman syndrome. J Am Soc Nephrol. 2011;22(4):693–703.CrossRef
20.
go back to reference Singh RK, Cooper TA. Pre-mRNA splicing in disease and therapeutics. Trends Mol Med. 2012;18(8):472–82.CrossRef Singh RK, Cooper TA. Pre-mRNA splicing in disease and therapeutics. Trends Mol Med. 2012;18(8):472–82.CrossRef
21.
go back to reference Takahara K, Schwarze U, Imamura Y, Hoffman GG, Toriello H, Smith LT, et al. Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I. Am J Hum Genet. 2002;71(3):451–65.CrossRef Takahara K, Schwarze U, Imamura Y, Hoffman GG, Toriello H, Smith LT, et al. Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I. Am J Hum Genet. 2002;71(3):451–65.CrossRef
22.
go back to reference Shao L, Liu L, Miao Z, Ren H, Wang W, Lang Y, et al. A novel SLC12A3 splicing mutation skipping of two exons and preliminary screening for alternative splice variants in human kidney. Am J Nephrol. 2008;28(6):900–7.CrossRef Shao L, Liu L, Miao Z, Ren H, Wang W, Lang Y, et al. A novel SLC12A3 splicing mutation skipping of two exons and preliminary screening for alternative splice variants in human kidney. Am J Nephrol. 2008;28(6):900–7.CrossRef
23.
go back to reference Mudge JM, Frankish A, Harrow J. Functional transcriptomics in the post-ENCODE era. Genome Res. 2013;23(12):1961–73.CrossRef Mudge JM, Frankish A, Harrow J. Functional transcriptomics in the post-ENCODE era. Genome Res. 2013;23(12):1961–73.CrossRef
24.
go back to reference Takeuchi Y, Mishima E, Shima H, Akiyama Y, Suzuki C, Suzuki T, et al. Exonic mutations in the SLC12A3 gene cause exon skipping and premature termination in Gitelman syndrome. J Am Soc Nephrol. 2015;26(2):271–9.CrossRef Takeuchi Y, Mishima E, Shima H, Akiyama Y, Suzuki C, Suzuki T, et al. Exonic mutations in the SLC12A3 gene cause exon skipping and premature termination in Gitelman syndrome. J Am Soc Nephrol. 2015;26(2):271–9.CrossRef
Metadata
Title
Inherited, not acquired, Gitelman syndrome in a patient with Sjögren’s syndrome: importance of genetic testing to distinguish the two forms
Authors
Eikan Mishima
Takayasu Mori
Eisei Sohara
Shinichi Uchida
Takaaki Abe
Sadayoshi Ito
Publication date
01-11-2017
Publisher
Springer Singapore
Published in
CEN Case Reports / Issue 2/2017
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-017-0271-4

Other articles of this Issue 2/2017

CEN Case Reports 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine